HINJ 2013 Economic Impact Report

Download ‘HINJ’s 2013
Economic Impact Report’

 

HINJ and New Jersey's Life Sciences Community Brochure

Download HINJ and New
Jersey’s Life Sciences Community

 

Building-Bridges 

Download the Report

 

 

HINJ CEO INTERVIEW ON NJTV NEWS:  NJ WILL CONTINUE TO BE STRONG WITHIN MEDICAL INDUSTRY

New Jersey has traditionally served as headquarters for life sciences companies and been a major part of the medical industry.  In an interview broadcast on April 10 on “NJTV News with Mike Schneider,” HINJ President and Chief Executive Officer Dean Paranicas said he believes the state will continue to be strong even in the changing health care climate. 

 

While some limitations exist, and changes have occurred within the industry, Paranicas said that he is optimistic that New Jersey has outstanding assets that work in the state’s favor.

 

“I think we continue to be very important,” Paranicas said.  “We are very proud of the fact that we are known globally as the medicine chest of the world, and we certainly intend to keep it that way.”

 

For the complete story, click here.

 

 

HINJ AND WWFH-NJ TO HOST FREE ‘NAVIGATING THE POLICYMAKING PROCESS’ WORKSHOP ON MAY 1

Please join HINJ and We Work for Health New Jersey (WWFH-NJ) for “Navigating the Policymaking Process,” which will be held on Thursday, May 1 at Forsgate Country Club in Monroe Township.

 

The purpose of the May 1 panel discussion is to provide Rx4NJ partners and others in New Jersey’s patient advocacy community useful information on how to effectively navigate the policymaking process on behalf of their patient constituencies.

Speakers and panelists include Assemblyman Troy Singleton (D-7) and Amanda Woloshen, District Director, Office of Congressman Leonard Lance (R-NJ-7).

For additional information, click here.

 

 

HINJ PLEASED AGAIN TO COSPONSOR PHARMFEST; PHRMA CEO JOHN CASTELLANI KEYNOTED

The HealthCare Institute of New Jersey (HINJ) was pleased to partner, once again, with Montclair State University to sponsor PharmFest, a premier forum that explores emerging issues and trends in the biopharmaceutical and medical technology industry. 

“PharmFest 2014: The Decade Ahead” was held on April 3 in the Conference Center on the campus of Montclair State University.

Keynote addresses were presented by John J. Castellani, President and Chief Executive Officer of the Pharmaceutical and Research Manufacturers of America (PhRMA) and Dr. Richard Evans, Founding Partner and Research Analyst at Sector & Sovereign Research, LLC and author of Health and Capital. 

For additional information, click here.

 

 

HINJ AND NEHI HOST ‘INNOVATION IN AN ERA OF PAYMENT REFORM’ FORUM

HINJ and NEHI (The Network for Excellence in Health Innovation) hosted a forum on “Innovation in an Era of Payment Reform: How Will New Jersey’s Life Sciences Companies Respond?” on April 1 at the Crowne Plaza in Monroe Township, NJ.

Health care payment reform is already transforming the way health care providers deliver care throughout the United States.  Payment reform will not only influence the quality and cost of health care, it will also impact innovation in New Jersey’s historically dynamic life sciences sector. 

HINJ and NEHI’s roundtable brought stakeholders and policymakers together from all New Jersey health care sectors to explore the opportunities for medical innovation in this new environment, the direction innovation could take, the potential challenges that will be involved, and how innovation can be a solution to lowering the cost of health care in this new payment model.

For additional information, click here.

 

 

‘NJTV NEWS’ REPORTS ON NJ LIFE SCIENCES, HINJ’S 2012 ECONOMIC IMPACT SURVEY

It has been called the crown jewel of the New Jersey economy.  Citing HINJ’s latest economic impact survey, Lauren Wanko reported on “NJTV News with Mike Schneider” that the biopharmaceutical and medical technology industries generated over $26 billion in economic impact for the Garden State in 2012. 

“We call this the ‘Medicine Chest of the World,’” said HINJ President and Chief Executive Officer Dean Paranicas.  “This is New Jersey’s premier industry.  In fact, we have the largest concentration of companies of its type in the world.” 

The HINJ economic impact study indicates a nearly 10 percent increase in economic activity from 2010. 

To view the NJTV News segment, click here.

 

 

HINJ MEMBER COMPANIES’ ECONOMIC IMPACT EXCEEDS $26 BILLION IN 2012, FINDS NEW STUDY CONDUCTED IN ASSOCIATION WITH DELOITTE

Key findings from the HINJ 2012 economic impact survey indicate that the life sciences continues to play a leading role in driving New Jersey’s economy and reinforces the state’s reputation as the “Medicine Chest of the World.”

According to the study, which was conducted by Deloitte for the ninth consecutive year, participating HINJ member companies had a total impact on New Jersey’s economy of $26.6* billion in calendar year 2012, a healthy increase of 9.9 percent from 2010.

“HINJ member companies continue to be a major force in New Jersey’s economy in their pursuit of advancing global health,” said Dean J. Paranicas, President and Chief Executive Officer of HINJ.  “Our enduring goal is for patients everywhere to have access to the medicines, therapies and medical technologies they critically need.”

The 2012 survey also measured participating HINJ member companies’ activities in research and development (R&D), vendor spending, capital spending, philanthropy, employment and compensation.

To read the complete news story, click here.

 

HINJ Honors Six at Inaugural Life Sciences Celebration

The HealthCare Institute of New Jersey (HINJ) honored five New Jersey leaders and a nationally recognized high school on September 25, 2013, for their contributions in human health, public service, patient advocacy, life sciences, and science, technology, engineering and mathematics (STEM) education. 

The awards were presented at HINJ’s inaugural Life Sciences Celebration, which was held at the Renaissance Woodbridge Hotel in Iselin, NJ.

Those recognized included former Governor Thomas H. Kean, the late United States Senator Frank R. Lautenberg, Dr. Christopher J. Molloy, Dr. Joseph R. Bertino, Dr. Debra L. Wentz, and Biotechnology High School.

HINJ was pleased to host three former New Jersey Governors.  In addition to Governor Kean, Governor Brendan Byrne and Governor James Florio attended the event.

To read the news story, click here.

 

WELCOME

Thank you for visiting HealthCare Institute of New Jersey (HINJ) online — and welcome to our new website!

Since our founding in 1997, HINJ has served as the voice of New Jersey’s life sciences industry, which is comprised of biopharmaceutical and medical technology companies. 

Engaged in a broad range of activities throughout New Jersey, in Washington, DC and around the nation, HINJ’s work focuses on four key themes:

  • Promoting patient access to cutting-edge medicines, therapies and medical technologies
  • Bolstering an “Innovation Ecosystem” that develops advances in human health
  • Building awareness of the life sciences industry’s contributions to New Jersey’s economy
  • Helping advance corporate social responsibility, which is a hallmark of the life sciences companies

Our aim with this website is to provide information about these themes to the many who engage New Jersey’s life sciences community.

As we continue to expand our new website in the coming weeks, we hope you will find it to be a content-rich and easy-to-navigate resource.  We welcome your feedback as we move forward.

Sincerely,

Dean J. Paranicas
President and Chief Executive Officer

 

 

Password Reset

Please enter your e-mail address. You will receive a new password via e-mail.